Emergent Biosolutions Inc
EBS
Market Cap$97.45M
Close$
$13.00
566.6% upside
Current Fair Value
566.6% upsideUndervalued by 566.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $97.45 Million |
|---|---|
| Enterprise Value | $845.95 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-14.85 |
| Beta | 1.58 |
| Outstanding Shares | 52,390,764 |
| Avg 30 Day Volume | 1,036,154 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.13 |
|---|---|
| PEG | 0.32 |
| Price to Sales | 0.1 |
| Price to Book Ratio | 0.16 |
| Enterprise Value to Revenue | 0.81 |
| Enterprise Value to EBIT | -4.2 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.02 |
| Debt to Equity | 1.32 |
Revenue Sources
No data
ESG Score
No data
About Emergent Biosolutions Inc
CEO: Robert Kramer